| Author |
Wang, YK; Ma, N; Xu, S; Huang, JY; Ni, QZ; Cao, HJ; Zheng, QW; Zhu, B; Xia, J; Zhang, FK; Ding, XF; Qiu, XS; Chan, TW; Wang, K; Chen, W; Li, ZG; Cheng, SQ; Xie, D; Li, JJ |
| Abstract |
Pancreatic progenitor cell differentiation and proliferation factor (PPDPF) has been reported to play a role in tumorigenesis. However, its function in hepatocellular carcinoma (HCC) remains poorly understood. In this study, we report that PPDPF is significantly downregulated in HCC and the decreased PPDPF expression in-dicates poor prognosis. In the dimethylnitrosamine (DEN)-induced HCC mouse model, hepatocyte-specific depletion of Ppdpf promotes hepatocarcinogenesis, and reintroduction of PPDPF into liver-specific Ppdpf knockout (LKO) mice inhibits the accelerated HCC development. Mechanistic study shows that PPDPF reg-ulates nuclear factor KB (NF-KB) signaling through modulation of RIPK1 ubiquitination. PPDPF interacts with RIPK1 and facilitates K63-linked ubiquitination of RIPK1 via recruiting the E3 ligase TRIM21, which catalyzes K63-linked ubiquitination of RIPK1 at K140. In addition, liver-specific overexpression of PPDPF activates NF-KB signaling and attenuates apoptosis and compensatory proliferation in mice, which significantly sup-presses HCC development. This work identifies PPDPF as a regulator of NF-KB signaling and provides a po-tential therapeutic candidate for HCC. |
